Abivax (ABVX) Short term Debt (2021 - 2025)
Abivax's Short term Debt was $47.74 million in Q1 2025.
Powered by 
Analysis
Abivax (ABVX) Short term Debt (2021 - 2025) Analysis & Trends
At the end of FY2023, Short term Debt at Abivax came in at $3.53 million, up 2.6% from FY2022.
- In earlier years, Short term Debt was $3.44 million in FY2022 (-48.7%) and $6.7 million in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Abivax | 7.15 Bn | 7.15 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 47.74 Mn |
| Jun 30, 2024 | 2.67 Mn |
| Dec 31, 2023 | 3.51 Mn |
| Dec 31, 2022 | 3.33 Mn |
| Dec 31, 2021 | 6.47 Mn |
API Access
Abivax Short term Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-debt&ticker=ABVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-debt", "ticker": "ABVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-debt&ticker=ABVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();